• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Scand J Immunol . Humoral and Cellular Immune Responses in Critically Ill Influenza A/H1N1 Infected Patients

tetano

Editor, Senior Moderator
Scand J Immunol


. 2021 Apr 23;e13045.
doi: 10.1111/sji.13045. Online ahead of print.
Humoral and Cellular Immune Responses in Critically Ill Influenza A/H1N1 Infected Patients


Abira Paramsothy[SUP] 1 [/SUP], Sarah Lartey Jalloh[SUP] 1 [/SUP], Richard A Davies[SUP] 1 [/SUP], Anne-Berit Guttormsen[SUP] 2 3 [/SUP], Rebecca J Cox[SUP] 1 4 [/SUP], Kristin G-I Mohn[SUP] 1 5 [/SUP]



Affiliations

Abstract

There is limited knowledge of influenza-specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by hemagglutination inhibition, microneutralization, ELISA and ELLA assays. Influenza-specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells responses to conserved influenza epitopes (M1, NP and PB1) were analyzed by Fluorospot. Overall, the patients retained a high level of functional HA- and NA-specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared to H1 head-specific antibodies. The NA-specific antibodies and the non-neutralizing HA-specific antibody response for H1 head and H1 full-length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full-length protein remained low at all time points. Similarly, CD8[SUP]+[/SUP] T-cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA specific antibody avidity and CD8[SUP]+[/SUP] T-cell response.

Keywords: Critical illness; Immune response; Influenza A/H1N1.
 
Back
Top